While one AGS patient with biallelic SAMHD1 GVs and chronic lymphocytic leukemia has been described [17], heterozygous GVs in SAMHD1 have been detected in a multiple myeloma family and significantly associated with prostate cancer risk [13, 52]. Here, SAMHD1 is linked to prostate cancer.